Memorial Sloan Kettering Cancer Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Memorial Sloan Kettering Cancer Center sits in the top decile of US sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count).
Memorial Sloan Kettering Cancer Center: 1,884 sponsored US clinical trials, 327 recruiting.
Memorial Sloan Kettering Cancer Center sponsors 1,884 registered US clinical trials on ClinicalTrials.gov, 327 of them currently recruiting, and 1,104 completed. 75 of these trials are in Phase 3-4 (later-stage) and 1,101 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 98 trials.
Top-decile sponsor footprint
Memorial Sloan Kettering Cancer Center ranks in the top decile of sponsors by registered trial count (#6 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,884 total, page 9 of 38
Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease
NCT05048459
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
NCT05036252
Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery
NCT05025020
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
NCT04897022
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer
NCT04997018
A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone
NCT05038124
A Study of N9 Chemotherapy in Children With Neuroblastoma
NCT04947501
A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
NCT04920084
A Study of a Telemedicine Program for Older Adults With Cancer
NCT04917848
Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors
NCT04916249
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
NCT04722172
A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer
NCT04905316
Stool Transplant to Control Treatment-related Diarrhea
NCT04883762
A Study of Attention and Memory Processes in Breast Cancer Survivors
NCT04883398
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
NCT04416451
A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
NCT04872595
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
NCT04854005
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer
NCT04848961
The Effect of Acupuncture on Cancer-Related Cognitive Difficulties
NCT04837820
An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma
NCT04837833
Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma
NCT04784247
Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma
NCT04792073
A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer
NCT04802720
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy
NCT04769960
Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders
NCT04761770
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
NCT04757363
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
NCT04716946
Using e-Nose Technology to Identify Early Lung Cancer
NCT04734145
A Study of Risk Factors for the COVID-19 Virus Infection
NCT04697927
A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
NCT04666740
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
NCT04673266
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)
NCT04447768
Testing a New Imaging Agent to Identify Cancer
NCT04692831
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer
NCT04648904
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
NCT04643015
Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer
NCT04457284
A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
NCT04624178
Laser Ablation of Papillary Thyroid Microcarcinoma
NCT04623801
Researching the Effect of Exercise on Cancer
NCT04589468
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
NCT04577326
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
NCT04569773
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
NCT04552288
Safety of Lung Cryobiopsy in People With Cancer
NCT04548830
MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma
NCT04555551
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
NCT04544111
Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver
NCT04544098
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
NCT04497961
Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
NCT03245541
PREPARE: Patient Centered Perioperative Experience
NCT04472117
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
NCT04469075
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 461 |
| Phase 2 | 640 |
| Phase 3 | 67 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Memorial Sloan Kettering Cancer Center pipeline
327 recruiting of 1,884 indexed (17% open); 1,104 completed (59%).
Phase mix: 75 late (III/IV) vs 1,101 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (98 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.